Tag Archives: Early-stage trial data on AstraZeneca COVID-19 vaccine due Monday

LONDON: Early-stage human trial data on a vaccine being developed by AstraZeneca and Oxford University will be published on July 20, The Lancet medical journal said on Wednesday. The vaccine candidate is already in large-scale Phase III human trials to assess whether it can protect against COVID-19, but its developers have yet to report Phase I results which would show …

Read More »